S Structure Therapeutics Inc.: management transactions · United States · SEC (Form 4) Browse the full management transaction log of Structure Therapeutics Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €2.8bn. The latest transaction was disclosed on 18 March 2025 (Attribution). Among the most active insiders: Stevens Raymond C. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 18 March 2025
All Executives21 Thresholds0 Prospectus0 Other0
Declarations 21 total
◆ Chief Medical Officer · Executives · 15 Mar 2025
116,988 shares 0Ordinary Shares SEC:0001415889-25-008555:0
◆ CHIEF SCIENTIFIC OFFICER · Executives · 15 Mar 2025
80,829 shares 0Ordinary Shares SEC:0001415889-25-008552:0
◆ CHIEF EXECUTIVE OFFICER · Executives · 15 Mar 2025
340,332 shares 0Ordinary Shares SEC:0001415889-25-008550:0
◆ Chief Development Officer · Executives · 15 Mar 2025
51,048 shares 0Ordinary Shares SEC:0001415889-25-008554:0
◆ CHIEF FINANCIAL OFFICER · Executives · 15 Mar 2025
170,166 shares 0Ordinary Shares SEC:0001415889-25-008551:0
◆ CHIEF TECHNOLOGY OFFICER · Executives · 15 Mar 2025
63,810 shares 0Ordinary Shares SEC:0001415889-25-008553:0
◆ Chief Development Officer · Executives · 18 Sept 2024
67,290 shares 0Ordinary Shares SEC:0001415889-24-023794:0
◆ Chief Medical Officer · Executives · 18 Sept 2024
90,600 shares 0Ordinary Shares SEC:0001415889-24-023791:0
◇ CHIEF EXECUTIVE OFFICER · Executives · 12 Jun 2024
99,999 shares @ US$0.39 100.0% of flow Ordinary Shares SEC:0001415889-24-017040:0
● CHIEF EXECUTIVE OFFICER · Executives · 10 Jun 2024
555,000 shares 0Ordinary Shares SEC:0001415889-24-016510:0
◇ CHIEF SCIENTIFIC OFFICER · Executives · 3 Jun 2024
106,200 shares @ US$0.34 100.0% of flow Ordinary Shares SEC:0001415889-24-015683:0
◆ CHIEF TECHNOLOGY OFFICER · Executives · 15 Mar 2024
36,729 shares 0Ordinary Shares SEC:0001415889-24-008569:0
◆ CHIEF FINANCIAL OFFICER · Executives · 15 Mar 2024
59,469 shares 0Ordinary Shares SEC:0001415889-24-008566:0
◆ CHIEF SCIENTIFIC OFFICER · Executives · 15 Mar 2024
85,707 shares 0Ordinary Shares SEC:0001415889-24-008572:0
◆ CHIEF EXECUTIVE OFFICER · Executives · 15 Mar 2024
134,682 shares 0Ordinary Shares SEC:0001415889-24-008561:0
◆ CHIEF MEDICAL OFFICER · Executives · 15 Mar 2024
26,235 shares 0Ordinary Shares SEC:0001415889-24-008567:0
4,018,253 shares Ordinary Shares, $0.0001 par value per share SEC:0001193805-23-000724:0
965,115 shares Ordinary Shares SEC:0000315066-23-002162:0
● Director · Executives · 7 Feb 2023
642,245 shares Ordinary Shares SEC:0001209191-23-008166:0
● Director · Executives · 7 Feb 2023
123,508 shares Ordinary Shares SEC:0001209191-23-008168:0
4,013,678 shares Ordinary Shares SEC:0000318989-23-000054:0